The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Shares Gain And Pound Falls On Tame UK Inflation

Tue, 19th Aug 2014 16:19

LONDON (Alliance News) - UK markets made strong gains for the second consecutive day, as investors took heart that geopolitical tensions seemed to be contained for the time being.

However, the pound dropped to its lowest level against the dollar for four months following the release of a lower-than-expected UK inflation reading.

The FTSE 100 ended the day up 0.6% at 6,779.31, and the FTSE 250 added 0.6% to 15,895.26, while the AIM All-Share gained 0.5% to 763.29.

In Europe markets performed even better, with the CAC 40 in Paris ending up 0.6%. while the German DAX finished 1.0% higher.

At the close of European markets, Wall Street also was trading higher. The DJIA was up 0.4%, the S&P 500 up 0.4% and the NASDAQ Composite up 0.2%.

UK consumer prices rose by 1.6% year-on-year in July, according to the latest data from the Office for National Statistics. That's down from the 1.9% rise in prices in June, and lower than the 1.8% CPI that had been predicted by economists. On a monthly basis, prices fell by 0.3%, reversing the 0.2% rise in June and falling faster that the 0.2% fall that had been expected.

The Bank of England is mandated to target CPI of 2.0%. The latest data represents a slip away from that goal and the seventh consecutive month of below-target inflation. The data will support the recent shift in market sentiment toward believing that UK interest rates are unlikely to rise until next year.

"Lower levels of inflation take the heat off the Bank of England to hike rates. This latest report won’t have been factored into the decision-making at the latest BOE meeting, but with core inflation below 2% anyway it seems entirely possible no members of the Monetary Policy Committee dissented the decision to keep interest rates unchanged," says Jasper Lawler, analyst at CMC Markets.

Wednesday's economic calendar is dominated by central banks, as minutes from the most recent Bank of England and Federal Reserve meetings will be released at 0930 BST and 1900 BST, respectively.

The pound was hit by the UK inflation news and was trading at USD1.6621 at the close of play in London.

In individual stock news, BHP Billiton was by some distance the biggest faller in the FTSE 100 after it confirmed that it will demerge its aluminium, coal, manganese, nickel and silver assets into a new company, pledging to cut costs and improve the productivity of its remaining businesses in an attempt to boost shareholder returns. The new Perth-based entity will be listed in Sydney and Johannesburg, rather than London.

The stock was further pushed down, according to Liberum, by BHP's failure to announce a "much anticipated" USD3 billion to USD5 billion share buyback. BHP ended the day down 4.5%.

Imperial Tobacco Group closed up 2.1% after it reported a slight fall in sales volume and revenue for the first nine months of its financial year, but left unchanged its full-year guidance for "modest" growth in earnings per share and a dividend increase of at least 10%.

Imperial Tobacco said its stock optimisation programme - by which it is reducing stock levels to improve supply and cost efficiencies - reduced trade inventories in a number of markets, especially Iraq and Russia, which has hit volume, revenue and profit. However, the company still expects "modest growth" in earnings per share at constant currency rates for the full financial year, accompanied by at least a 10% increase in dividend. It also said its cost-optimisation programme remains on track to deliver incremental savings of GBP60 million for the full year.

In the corporate calendar Wednesday, interim results will be reported from Glencore, Hikma Pharmaceuticals, Harvey Nash and UK Commercial Property Trust.

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.